New COVID-19 Vaccine A Good Value for U.S., U-M Team Finds

November 2, 2023


Read time:

<5 mins
Doctor Disinfects Skin Of Patient Before Vaccination

A new economic analysis from a team of U-M researchers reports that investing in updated vaccination for adults across all ages, especially those in their late 50s to early 60s, would be worth it, relative to the money spent by U.S. insurers and government healthcare programs. Widespread vaccination lowers rates of hospitalizations, critical illness, long COVID, and deaths. The U-M team presented this analysis to the Center for Disease Control on September 12th.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.